Related references
Note: Only part of the references are listed.Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases
Christopher Huynh et al.
NATURE REVIEWS NEPHROLOGY (2023)
Bioactive lipid-nanoparticles with inherent self-therapeutic and anti-angiogenic properties for cancer therapy
Shuwen Cao et al.
ACTA BIOMATERIALIA (2023)
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts
Martin Mynarek et al.
ACTA NEUROPATHOLOGICA (2023)
Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy
Solmaz Mojarad-Jabali et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy
YuLing Yang et al.
JOURNAL OF CONTROLLED RELEASE (2022)
DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathway
Liu Liu et al.
SCIENCE SIGNALING (2022)
Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy
Xiaoxuan Xu et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2
Ping Xue et al.
CELL DEATH AND DIFFERENTIATION (2022)
Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer
Hongyi Chen et al.
BIOMATERIALS (2022)
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse
Stacey Richardson et al.
NEURO-ONCOLOGY (2022)
Iron oxide nanoparticle-mediated radiation delivery for glioblastoma treatment
Peter A. Chiarelli et al.
MATERIALS TODAY (2022)
Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma
Rafael Roesler et al.
NEURO-ONCOLOGY (2022)
Non-Invasive Transdermal Delivery Systems with Deep Tissue Penetrating Ability for Local ROS-Modulating Chemotherapy
ChengYu Deng et al.
ADVANCED FUNCTIONAL MATERIALS (2022)
PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
Jiaqing Yi et al.
CANCER RESEARCH (2022)
Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma
Michelle M. M. Kameda-Smith et al.
NATURE COMMUNICATIONS (2022)
A Druggable UHRF1/DNMT1/GLI Complex Regulates Sonic Hedgehog-Dependent Tumor Growth
Fan Yang et al.
MOLECULAR CANCER RESEARCH (2022)
Nonenzymatic Multiamplified Electrochemical Detection of Medulloblastoma-Relevant MicroRNAs from Cerebrospinal Fluid
Yujie Liu et al.
ACS SENSORS (2022)
Failure of human rhombic lip differentiation underlies medulloblastoma formation
Liam D. Hendrikse et al.
NATURE (2022)
Miat and interacting protein Metadherin maintain a stem-like niche to promote medulloblastoma tumorigenesis and treatment resistance
Kai-Lin Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
Jessica B. Foster et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy
Bin Wang et al.
BIOACTIVE MATERIALS (2022)
Tumour immunotherapy: lessons from predator-prey theory
Phineas T. Hamilton et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Iron oxide nanoparticle-mediated radiation delivery for glioblastoma treatment
Peter A. Chiarelli et al.
MATERIALS TODAY (2022)
Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growth
Evelina Miele et al.
MOLECULAR ONCOLOGY (2021)
Pediatric CNS imaging and long-term effects of irradiation in pediatric oncology patients
Sara Kluge et al.
PEDIATRICS INTERNATIONAL (2021)
Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma
Virender Kumar et al.
BIOMATERIALS (2021)
Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation
Heyu Song et al.
CANCER LETTERS (2021)
Medulloblastoma-associated mutations in the DEAD-box RNA helicase DDX3X/DED1 cause specific defects in translation
Nicolette P. Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
An immunohistochemical study of lymphatic elements in the human brain
Eva Mezey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond
Jesus Garcia-Lopez et al.
TRENDS IN GENETICS (2021)
Tomato Bushy Stunt Virus Nanoparticles as a Platform for Drug Delivery to Shh-Dependent Medulloblastoma
Chiara Lico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor
Sheng-Kai Wu et al.
PHARMACEUTICS (2021)
Targeted Regulation of Blood-Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma
Lingtong Meng et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma
Paola Infante et al.
CANCER LETTERS (2021)
Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance
Phillip M. Galbo et al.
CLINICAL CANCER RESEARCH (2021)
Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
Marta Buzzetti et al.
SCIENTIFIC REPORTS (2021)
Liposome-Imipramine Blue Inhibits Sonic Hedgehog Medulloblastoma In Vivo
Tobey J. MacDonald et al.
CANCERS (2021)
BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment
Wenli Chen et al.
JOURNAL OF CONTROLLED RELEASE (2021)
GD2 CAR T cells against human glioblastoma
Malvina Prapa et al.
NPJ PRECISION ONCOLOGY (2021)
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
G. K. Friedman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Drug penetration in pediatric brain tumors: Challenges and opportunities
Jenny P. Patel et al.
PEDIATRIC BLOOD & CANCER (2021)
Single-cell analysis reveals effective siRNA delivery in brain tumors with microbubble-enhanced ultrasound and cationic nanoparticles
Yutong Guo et al.
SCIENCE ADVANCES (2021)
Subgroup and subtype-specific outcomes in adult medulloblastoma
Hallie Coltin et al.
ACTA NEUROPATHOLOGICA (2021)
Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy
Zahraa F. Audi et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)
Cavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening
Robin Ji et al.
JOURNAL OF CONTROLLED RELEASE (2021)
The MYC oncogene - the grand orchestrator of cancer growth and immune evasion
Renumathy Dhanasekaran et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Extracellular vesicle-associated organotropic metastasis
Zhenzhen Mo et al.
CELL PROLIFERATION (2021)
Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice
Joshua D. Bernstock et al.
CANCER GENE THERAPY (2020)
Identification of Novel Medulloblastoma Cell-Targeting Peptides for Use in Selective Chemotherapy Drug Delivery
Kristel C. Tjandra et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Formulation and evaluation of itraconazole liposomes for Hedgehog pathway inhibition
Jennifer R. Pace et al.
JOURNAL OF LIPOSOME RESEARCH (2020)
EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway
Hanwen Zhang et al.
ONCOGENE (2020)
Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors
Dezhong Ji et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Modeling pediatric medulloblastoma
Martine F. Roussel et al.
BRAIN PATHOLOGY (2020)
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Pathology, diagnostics, and classification of medulloblastoma
Brent A. Orr
BRAIN PATHOLOGY (2020)
Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma
Guiping Zhao et al.
CANCER MEDICINE (2020)
Modulating the Selectivity and Stealth Properties of Ellipsoidal Polymersomes through a Multivalent Peptide Ligand Display
Kristel C. Tjandra et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Medulloblastoma Arises from the Persistence of a Rare and Transient Sox2+ Granule Neuron Precursor
Hayden J. Selvadurai et al.
CELL REPORTS (2020)
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Laura K. Donovan et al.
NATURE MEDICINE (2020)
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma
Soumen Khatua et al.
NEURO-ONCOLOGY (2020)
Recent Strategies for Targeted Brain Drug Delivery
Koki Ogawa et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2020)
DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma
Deanna M. Patmore et al.
DEVELOPMENTAL CELL (2020)
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors
Joshua D. Bernstock et al.
HUMAN GENE THERAPY (2020)
Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human
Wandong Zhang et al.
FLUIDS AND BARRIERS OF THE CNS (2020)
ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice
Qiyue Wang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Dissecting the Pol II transcription cycle and derailing cancer with CDK inhibitors
Pabitra K. Parua et al.
NATURE CHEMICAL BIOLOGY (2020)
Astrocytes influence medulloblastoma phenotypes and CD133 surface expression
Emily Gronseth et al.
PLOS ONE (2020)
Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review
Grzegorz Slawinski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Medulloblastoma epigenetics and the path to clinical innovation
Amanda R. Haltom et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma
Jinhwan Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Wnt activation as a therapeutic strategy in medulloblastoma
Branavan Manoranjan et al.
NATURE COMMUNICATIONS (2020)
In Situ Surface Modification of Microfluidic Blood-Brain-Barriers for Improved Screening of Small Molecules and Nanoparticles
Bo Peng et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137
Jiajia Wang et al.
CELL DEATH & DISEASE (2020)
Immunotherapy for Medulloblastoma: Current Perspectives
Tanvir F. Kabir et al.
IMMUNOTARGETS AND THERAPY (2020)
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas
Andrey Korshunov et al.
NEURO-ONCOLOGY (2019)
Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme
Rameshwar Patil et al.
BIOMATERIALS (2019)
Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastoma
Youjia Han et al.
CANCER LETTERS (2019)
Medulloblastoma
Paul A. Northcott et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma et al.
ACTA NEUROPATHOLOGICA (2019)
Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
Ae Kyung Park et al.
BMC CANCER (2019)
Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy
Franziska Blaeschke et al.
CYTOTHERAPY (2019)
Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma
Victor Maximov et al.
NATURE COMMUNICATIONS (2019)
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
Allison B. Powell et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Microenvironmental Heterogeneity in Brain Malignancies
Lucas J. M. Perus et al.
FRONTIERS IN IMMUNOLOGY (2019)
Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications
Tarik Moroy et al.
FRONTIERS IN ONCOLOGY (2019)
Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases
Long Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment
Amy J. Petty et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Target engagement and intracellular delivery of mono- and bivalent LDL receptor-binding peptide-cargo conjugates: Implications for the rational design of new targeted drug therapies
K. Varini et al.
JOURNAL OF CONTROLLED RELEASE (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma
Gregory M. Shackleford et al.
PLOS ONE (2019)
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
Catherine Lee et al.
NATURE COMMUNICATIONS (2019)
Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug updates delivery applications and enhanced translational potential
Vibhuti Agrahari et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
The Roles of miRNAs in Medulloblastoma: A Systematic Review
Behrouz Mollashahi et al.
JOURNAL OF CANCER PREVENTION (2019)
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
Duaa O. Khair et al.
FRONTIERS IN IMMUNOLOGY (2019)
MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling
Bo Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Hedgehog signaling drives medulloblastoma growth via CDK6
David R. Raleigh et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Nanotherapeutic systems for local treatment of brain tumors
Rami Walid Chakroun et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2018)
M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
Chanhee Lee et al.
BMC CANCER (2018)
Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma
Domenico Orlando et al.
CANCER RESEARCH (2018)
Dual-targeting for brain-specific drug delivery: synthesis and biological evaluation
Qiming Yue et al.
DRUG DELIVERY (2018)
Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides
Yaqin Zhu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Rethinking medulloblastoma from a targeted therapeutics perspective
Yuuri Hashimoto et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma
Eric M. Thompson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
Sebastian M. Waszak et al.
LANCET ONCOLOGY (2018)
Strategies to target the Hedgehog signaling pathway for cancer therapy
Minhang Xin et al.
MEDICINAL RESEARCH REVIEWS (2018)
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
Sara Bolin et al.
ONCOGENE (2018)
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
Roberto Giugliani et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model
Dario Presutti et al.
PLOS ONE (2018)
PD-L1 expression in medulloblastoma: an evaluation by subgroup
Allison M. Martin et al.
Oncotarget (2018)
Self-assembling asymmetric peptide-dendrimer micelles - a platform for effective and versatile in vitro nucleic acid delivery
Ganesh R. Kokil et al.
SCIENTIFIC REPORTS (2018)
HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
Jonathan B. Bell et al.
SCIENTIFIC REPORTS (2018)
Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies
Jun Wang et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 41 (2018)
Impact of miRNA-mRNA Profiling and Their Correlation on Medulloblastoma Tumorigenesis
Vinod Kumar et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Epigenetic Regulation by BAF Complexes Limits Neural Stem Cell Proliferation by Suppressing Wnt Signaling in Late Embryonic Development
Huong Nguyen et al.
STEM CELL REPORTS (2018)
Subgroup-specific immune and stromal microenvironment in medulloblastoma
Michael Bockmayr et al.
ONCOIMMUNOLOGY (2018)
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
Anandani Nellan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier
Danica B. Stanimirovic et al.
BIODRUGS (2018)
Molecular characterization of Wnt pathway and function of -catenin overexpression in medulloblastoma cell lines
Lenisa Geron et al.
CYTOTECHNOLOGY (2018)
Epigenetic Drivers in Pediatric Medulloblastoma
Martine F. Roussel et al.
CEREBELLUM (2018)
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Oren J. Becher et al.
PEDIATRIC BLOOD & CANCER (2017)
Albumin nanoparticles for glutathione-responsive release of cisplatin: New opportunities for medulloblastoma
Giuseppina Catanzaro et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Edward C. Schwalbe et al.
LANCET ONCOLOGY (2017)
The whole-genome landscape of medulloblastoma subtypes
Paul A. Northcott et al.
NATURE (2017)
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Sharareh Gholamin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Neuroimaging of Brain Tumors: Pseudoprogression, Pseudoresponse, and Delayed Effects of Chemotherapy and Radiation
Joerg Dietrich et al.
SEMINARS IN NEUROLOGY (2017)
Chimeric antigen receptor T-cell therapy for glioblastoma
Analiz Rodriguez et al.
TRANSLATIONAL RESEARCH (2017)
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma
Sean T. Bailey et al.
NATURE COMMUNICATIONS (2017)
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
Y. Anraku et al.
NATURE COMMUNICATIONS (2017)
Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma
Sonia Coni et al.
SCIENTIFIC REPORTS (2017)
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J. Hogg et al.
CELL REPORTS (2017)
Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer
Vinod Kumar et al.
SCIENTIFIC REPORTS (2017)
Oncogenic role of cytomegalovirus in medulloblastoma?
Alejandro M. Hortal et al.
CANCER LETTERS (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO2@LDH for anti-neuroblastoma therapy
Rongrong Zhu et al.
ACTA BIOMATERIALIA (2017)
Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models
Michelle L. Cook Sangar et al.
CLINICAL CANCER RESEARCH (2017)
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells
Evelina Miele et al.
BMC CANCER (2017)
One-Step Facile Synthesis of Highly Magnetic and Surface Functionalized Iron Oxide Nanorods for Biomarker-Targeted Applications
Anamaria Orza et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M. G. Cavalli et al.
CANCER CELL (2017)
In search of druggable targets for GBM amino acid metabolism
Eduard H. Panosyan et al.
BMC CANCER (2017)
Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
Christina D. Pham et al.
CLINICAL CANCER RESEARCH (2016)
Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009
C. Altshuler et al.
BONE MARROW TRANSPLANTATION (2016)
HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma
Yanxin Pei et al.
CANCER CELL (2016)
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
Timothy N. Phoenix et al.
CANCER CELL (2016)
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
Guo-Hao Huang et al.
CANCER SCIENCE (2016)
MYC - a thorn in the side of cancer immunity
Stefani Spranger et al.
CELL RESEARCH (2016)
The therapeutic potential of natural killer cells to target medulloblastoma
Antonio Perez-Martinez et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development
Oliver Jonas et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
Neuroinvasion and Inflammation in Viral Central Nervous System Infections
Tobias Dahm et al.
MEDIATORS OF INFLAMMATION (2016)
MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma
Gessica Filocamo et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells
Shanghao Li et al.
NANOSCALE (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line
Javier de la Rosa et al.
TUMOR BIOLOGY (2016)
IDO1 involvement in mTOR pathway: A molecular mechanism of resistance to mTOR targeting in medulloblastoma
Valentina Folgiero et al.
ONCOTARGET (2016)
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Robert L. Bowman et al.
CELL REPORTS (2016)
Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3α/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
Barbara Bassani et al.
PLOS ONE (2016)
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
Rachelle G. Veenstra et al.
BLOOD (2015)
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Giles W. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Targeting GLI factors to inhibit the Hedgehog pathway
Paola Infante et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Overcoming Antigen Escape with CAR T-cell Therapy
Hollie J. Jackson et al.
CANCER DISCOVERY (2015)
miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47
Seung Yeob Yang et al.
Oncotarget (2015)
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies
Alessandra Drusco et al.
ONCOTARGET (2015)
PEG-b-AGE polymer coated magnetic nanoparticle probes with facile functionalization and anti-fouling properties for reducing non-specific uptake and improving biomarker targeting
Yuancheng Li et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
MiR-34a deficiency accelerates medulloblastoma formation in vivo
Theresa Thor et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Histone Deacetylase 6 Represents a Novel Drug Target in the Oncogenic Hedgehog Signaling Pathway
Pavan Kumar Dhanyamraju et al.
MOLECULAR CANCER THERAPEUTICS (2015)
SIOP PODC Adapted Treatment Recommendations for Standard-Risk Medulloblastoma in Low and Middle Income Settings
Jeannette Parkes et al.
PEDIATRIC BLOOD & CANCER (2015)
Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma
Zhen-Nan Ye et al.
NATURAL PRODUCTS AND BIOPROSPECTING (2015)
miR-326 Is Downstream of Sonic Hedgehog Signaling and Regulates the Expression of Gli2 and Smoothened
Zhihua Jiang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma
G. Fiaschetti et al.
BRITISH JOURNAL OF CANCER (2014)
Pyrvinium Attenuates Hedgehog Signaling Downstream of Smoothened
Bin Li et al.
CANCER RESEARCH (2014)
Design, synthesis and biological evaluation of brain targeting L-ascorbic acid prodrugs of ibuprofen with lock-in function
Yi Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
The role of stem cells and progenitors in the genesis of medulloblastoma
Jun Wang et al.
EXPERIMENTAL NEUROLOGY (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
Phase 1 Trial of Temsirolimus in Combination with Irinotecan and Temozolomide in Children, Adolescents and Young Adults with Relapsed or Refractory Solid Tumors: A Children's Oncology Group Study
Rochelle Bagatell et al.
PEDIATRIC BLOOD & CANCER (2014)
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program
Min H. Kang et al.
PEDIATRIC BLOOD & CANCER (2014)
Silencing of the miR-17∼92 Cluster Family Inhibits Medulloblastoma Progression
Brian L. Murphy et al.
CANCER RESEARCH (2013)
Discovery of NVP-LEQ506, a Second-Generation Inhibitor of Smoothened
Stefan Peukert et al.
CHEMMEDCHEM (2013)
Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
Amar Gajjar et al.
CLINICAL CANCER RESEARCH (2013)
Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma
M. Gutova et al.
GENE THERAPY (2013)
MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma
Sujatha Venkataraman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Quantitative analysis of the brain-targeted delivery of drugs and model compounds using nano-delivery systems
Luba Kozlovskaya et al.
JOURNAL OF CONTROLLED RELEASE (2013)
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhiping Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem
Daniel Grammel et al.
ACTA NEUROPATHOLOGICA (2012)
Pleiotropic effects of miR-183∼96∼182 converge to regulate cell survival, proliferation and migration in medulloblastoma
Shyamal Dilhan Weeraratne et al.
ACTA NEUROPATHOLOGICA (2012)
A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma
Daisuke Kawauchi et al.
CANCER CELL (2012)
Three decades of Wnts: a personal perspective on how a scientific field developed
Roel Nusse et al.
EMBO JOURNAL (2012)
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling
Flora Cimmino et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing program
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2012)
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target
Ninib Baryawno et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children
Sharon Conroy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth
Till Milde et al.
CLINICAL CANCER RESEARCH (2010)
Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects
Kamala Kesavan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Transventricular delivery of Sonic hedgehog is essential to cerebellar ventricular zone development
Xi Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
Shifeng Pan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
GDC-0449-A potent inhibitor of the hedgehog pathway
Kirk D. Robarge et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma
Tracy-Ann Read et al.
CANCER CELL (2009)
Multipotent CD15(+) Cancer Stem Cells in Patched-1-Deficient Mouse Medulloblastoma
Ryan J. Ward et al.
CANCER RESEARCH (2009)
The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog-Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog-Treated Cerebellar Neural Precursors
Paul A. Northcott et al.
CANCER RESEARCH (2009)
MicroRNA profiling in human medulloblastoma
Elisabetta Ferretti et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
AGT-181: Expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys
Ruben J. Boado et al.
JOURNAL OF BIOTECHNOLOGY (2009)
Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery
Qian Chen et al.
JOURNAL OF DRUG TARGETING (2009)
Glucose Promoiety Enables Glucose Transporter Mediated Brain Uptake of Ketoprofen and Indomethacin Prodrugs in Rats
Mikko Gynther et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma
Tamar Uziel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells
Zeng-Jie Yang et al.
CANCER CELL (2008)
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program
John M. Maris et al.
PEDIATRIC BLOOD & CANCER (2008)
Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling
W. J. Ingram et al.
ONCOGENE (2008)
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity
Roberta Castriconi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin
Xue Qing Lun et al.
CANCER RESEARCH (2007)
Evaluation of poly (glycerol-adipate) nanoparticle uptake in an In Vitro 3-D brain tumor co-culture model
W. Meng et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
Tumor paint:: A Chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci
Mandana Veiseh et al.
CANCER RESEARCH (2007)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Development of the deep cerebellar nuclei: Transcription factors and cell migration from the rhombic lip
AJ Fink et al.
JOURNAL OF NEUROSCIENCE (2006)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Multimutated herpes simplex virus G207 is a potent inhibitor of angiogenesis
J Cinatl et al.
NEOPLASIA (2004)
Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
T Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas
H Huber et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
